China's WuXi XDC to open 31% higher in Hong Kong trading debut
SYDNEY, Nov 17 (Reuters) - Chinese medical research
group WuXi XDC's shares are set to rise nearly 31% when the
stock starts trading on the Hong Kong Stock Exchange (HKEX) on
Friday.
The firm raised $470 million in its initial public offering,
the third-largest new share sale in the city in 2023.
(Reporting by Scott Murdoch in Sydney and Donny Kwok in Hong
Kong; Editing by Christopher Cushing)
((Scott.Murdoch@thomsonreuters.com;))
Recent news on WuXi XDC Cayman
See all newsBrief: Wuxi Apptec Announces Disposal Of 53.5 Mln Shares In Wuxi XDC Via Block Trade
HK-listed WuXi XDC hits 10-month peak on solid first-half results
Chinese drugmaker Wuxi XDC's first-half revenue rises on project expansion, acquisition
Brief: WuXi XDC Cayman Posts H1 Revenue Of RMB3,701.4 Million
WuXi XDC climbs on share purchases under company scheme